On the research front, we are seeing equally exciting progress. St. Jude has announced significant research advancements impacting patients with solid tumors, brain tumors, leukemias, sickle cell disease and infectious diseases, among others. Cutting-edge research facilities are in the works to further explore the origins of childhood cancer and drive better treatments.
A new world-class Data Center will support these efforts as well as our St. Jude Cancer Predisposition Program, which identifies children who are at increased genetic risk for cancer through genomic sequencing. And just this year, as part of the commitment to develop and educate the next generation of scientific leaders, St. Jude established the St. Jude Graduate School of Biomedical Sciences.
This is just the beginning of our commitment to advance our mission of finding cures and saving children. In total, we are investing $9 billion over 6 years to support and operate St. Jude and to expand our lifesaving mission. You can read the latest about these plans in the summer 2017 issue of Promise magazine.
In short, the dedicated faculty and staff of St. Jude are as committed today as they have been since the beginning of our mission to find the cures that will end the scourge of childhood cancer and other diseases that threaten the lives of children everywhere. Without the resources provided by generous and caring donors and volunteers like you, we could not dare to undertake such bold new plans. Your support enables us to dream, and thanks to you, St. Jude has become the leading private funder of pediatric cancer research.
I know that together, we can reach the day that Danny dreamed of: a day when no child will die in the dawn of life.